Cui, Yunyao
35  Ergebnisse:
Personensuche X
?
2

Zanubrutinib attenuates bleomycin-induced pulmonary fibrosi..:

Chen, Shanshan ; Wei, Yuli ; Li, Shimeng...
International Immunopharmacology.  113 (2022)  - p. 109316 , 2022
 
?
3

Zanubrutinib ameliorates lipopolysaccharide-induced acute l..:

Li, Xiaohe ; Wei, Yuli ; Li, Shimeng...
International Immunopharmacology.  111 (2022)  - p. 109138 , 2022
 
?
6

Cabozantinib ameliorates lipopolysaccharide-induced lung in..:

Li, Xiaohe ; Ma, Ling ; Wei, Yuli...
International Immunopharmacology.  101 (2021)  - p. 108327 , 2021
 
?
7

Pinocembrin relieves lipopolysaccharide and bleomycin induc..:

Gan, Wenhua ; Li, Xiaohe ; Cui, Yunyao...
International Immunopharmacology.  90 (2021)  - p. 107230 , 2021
 
?
 
?
10

Nonepimerizing Alkylation of H–P Species to Stereospecifica..:

Nie, Shao-Zhen ; Zhou, Zhong-Yang ; Wang, Ji-Ping...
The Journal of Organic Chemistry.  82 (2017)  18 - p. 9425-9434 , 2017
 
?
11

Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via ..:

Li, Xiaohe ; Huang, Kai ; Liu, Xiaowei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072668/.  , 2021
 
?
12

Protective Effect of Remdesivir Against Pulmonary Fibrosis ..:

Li, Xiaohe ; Liu, Rui ; Cui, Yunyao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427522/.  , 2021
 
?
13

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced ..:

Li, Xiaohe ; Bi, Zhun ; Liu, Shuaishuai...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753632/.  , 2019
 
1-15